Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort

International Journal of Cancer

Volumn 132, Issue 9, 2013, Pages 2164-2175

  Duell, Eric J ^a   Travier, Noémie ^a   Lujan Barroso, Leila ^a   Dossus, Laure ^b   Boutron Ruault, Marie Christine ^b   Clavel Chapelon, Françoise ^b   Tumino, Rosario ^c   Masala, Giovanna ^d   Krogh, Vittorio ^e   Panico, Salvatore ^f   Ricceri, Fulvio ^g   Redondo, Maria Luisa ^h   Dorronsoro, Miren ⁱ   Molina Montes, Esther ^i,j   Huerta, José M ^i,k   Barricarte, Aurelio ^i,l   Khaw, Kay Tee ^m   Wareham, Nick J ⁿ   Allen, Naomi E ^o   Travis, Ruth ^o   Siersema, Peter D ^p   Peeters, Petra H M ^p,q   Trichopoulou, Antonia ^r,s   Fragogeorgi, Eirini ^s   Oikonomou, Eleni ^r   Boeing, Heiner ^t   Schuetze, Madlen ^t   Canzian, Federico ^u   Lukanova, Annekatrin ^u   Tjønneland, Anne ^v   Roswall, Nina ^w   Overvad, Kim ^x   Weiderpass, Elisabete ^y   Gram, Inger Torhild ^y   Lund, Eiliv ^y   Lindkvist, Björn ^z   Johansen, Dorthe ^aa   Ye, Weimin ^ab,ac   Sund, Malin ^ac   Fedirko, Veronika ^ad   Jenab, Mazda ^ad   Michaud, Dominique S ^q   Riboli, Elio ^q   Bueno De Mesquita, H Bas ^p,ae   more..

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b INSERM   (France)

^c CIVILE M P AREZZO HOSPITAL   (Italy)

^d CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g Human Genetics Foundation   (Italy)

^h Department of Health and Health Care Services Council Asturias ^*  (Spain)

ⁱ CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^j ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^k Murcia Regional Health Authority   (Spain)

^l INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^m UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁿ INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q IMPERIAL COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^s HELLENIC HEALTH FOUNDATION   (Greece)

^t GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^u GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^v INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^w DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^x AARHUS UNIVERSITY   (Denmark)

^y UNIVERSITY OF TROMSØ   (Norway)

^z UNIVERSITY OF GOTHENBURG   (Sweden)

^aa LUND UNIVERSITY   (Sweden)

^ab KAROLINSKA INSTITUTE   (Sweden)

^ac UMEÅ UNIVERSITY   (Sweden)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ae NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

more..

Author keywords

CYP17A1; estrogens; hormones; menstruation; pancreatic cancer; reproduction; women

Indexed keywords

CYTOCHROME P450 17; SEX HORMONE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; CYP17A1 GENE; DISEASE ASSOCIATION; FEMALE; GENE; GENE LOCUS; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENARCHE; MENSTRUATION; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID METABOLISM;

ADENOCARCINOMA; ADULT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MENSTRUATION; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCTIVE HISTORY; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84874057343     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27875     Document Type: Article

References (50)

1. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-81.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Benz C, Hollander C, Miller B,. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res 1986; 46: 2276-81.
4. Bourhis J, Lacaine F, Augusti M, et al. Protective effect of oestrogen in pancreatic cancer. Lancet 1987; 2: 977.
5. Adami HO, Persson I, Hoover R, et al. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 833-9.
6. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, et al. Anthropometric and reproductive variables and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer 1992; 52: 24-29.
7. Cantor KP, Lynch CF, Johnson D,. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 1993; 4: 505-11.
8. Chang CC, Chiu HF, Yang CY,. Parity, age at first birth, and risk of death from pancreatic cancer: evidence from a cohort in Taiwan. Pancreas 2010; 39: 567-71.
9. Corbishley TP, Iqbal MJ, Wilkinson ML, et al. Circulating sex steroids and sex hormone binding globulin in pancreatic adenocarcinoma. Anticancer Res 1986; 6: 219-22.
10. Duell EJ, Holly EA,. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women. Am J Epidemiol 2005; 161: 741-7.
11. Duell EJ, Maisonneuve P, Baghurst PA, et al. Menstrual and reproductive factors and pancreatic cancer in the SEARCH program of the IARC. Cancer Causes Control 2009; 20: 1757-62.
12. Fernandez E, La Vecchia C, d'Avanzo B, et al. Menstrual and reproductive factors and pancreatic cancer risk in women. Int J Cancer 1995; 62: 11-4.
13. Fernandez E, Gallus S, Bosetti C, et al. Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer 2003; 105: 408-12.
14. Fyssas I, Syrigos KN, Konstandoulakis MM, et al. Sex hormone levels in the serum of patients with pancreatic adenocarcinoma. Horm Metab Res 1997; 29: 115-8.
15. Haines AP, Moss AR, Whittemore A, et al. A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol 1982; 103: 93-7.
16. Heuch I, Jacobsen BK, Albrektsen G, et al. Reproductive factors and pancreatic cancer risk: a Norwegian cohort study. Br J Cancer 2008; 98: 189-93.
17. Ji BT, Hatch MC, Chow WH, et al. Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 1996; 66: 432-7.
18. Kalapothaki V, Tzonou A, Hsieh CC, et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control 1993; 4: 375-82.
19. Karlson BM, Wuu J, Hsieh CC, et al. Parity and the risk of pancreatic cancer: a nested case-control study. Int J Cancer 1998; 77: 224-7.
20. Kreiger N, Lacroix J, Sloan M,. Hormonal factors and pancreatic cancer in women. Ann Epidemiol 2001; 11: 563-7.
21. Kvale G, Heuch I, Nilssen S,. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol 1994; 23: 691-9.
22. La Vecchia C, Negri E, Franceschi S, et al. Long-term impact of reproductive factors on cancer risk. Int J Cancer 1993; 53: 215-9.
23. Lin RS, Kessler II,. A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA 1981; 245: 147-52.
24. Lin Y, Kikuchi S, Tamakoshi A, et al. Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan collaborative cohort study for evaluation of cancer risk. J Gastroenterol 2006; 41: 878-83.
25. Lo AC, Soliman AS, El Ghawalby N, et al. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 2007; 35: 120-9.
26. Lucenteforte E, Zucchetto A, Bosetti C, et al. Reproductive and hormonal factors and pancreatic cancer risk in women. Pancreas 2011; 40: 460-3.
27. Mack TM, Yu MC, Hanisch R, et al. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986; 76: 49-60.
28. Navarro Silvera SA, Miller AB, Rohan TE,. Hormonal and reproductive factors and pancreatic cancer risk: a prospective cohort study. Pancreas 2005; 30: 369-74.
29. Prizment AE, Anderson KE, Hong CP, et al. Pancreatic cancer incidence in relation to female reproductive factors: Iowa Women's Health Study. JOP 2007; 8: 16-27.
30. Singh S, Baker PR, Poulsom R, et al. Expression of oestrogen receptor and oestrogen-inducible genes in pancreatic cancer. Br J Surg 1997; 84: 1085-9.
31. Skinner HG, Michaud DS, Colditz GA, et al. Parity, reproductive factors, and the risk of pancreatic cancer in women. Cancer Epidemiol Biomarkers Prev 2003; 12: 433-8.
32. Stevens RJ, Roddam AW, Green J, et al. Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2009; 18: 1457-60.
33. Teras LR, Patel AV, Rodriguez C, et al. Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of US women (United States). Cancer Causes Control 2005; 16: 1035-40.
34. Wynder EL, Mabuchi K, Maruchi N, et al. A case control study of cancer of the pancreas. Cancer 1973; 31: 641-8.
35. Zhang Y, Coogan PF, Palmer JR, et al. A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer. Cancer Causes Control 2010; 21: 473-8.
36. Olson SH, Bandera EV, Orlow I,. Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol 2007; 165: 235-45.
37. Setiawan VW, Schumacher FR, Haiman CA, et al. CYP17 genetic variation and risk of breast and prostate cancer from the national cancer institute breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2007; 16: 2237-46.
38. Sharp L, Cardy AH, Cotton SC, et al. CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review. Am J Epidemiol 2004; 160: 729-40.
39. Duell EJ, Holly EA, Kelsey KT, et al. Genetic variation in CYP17A1 and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Int J Cancer 2010; 126: 790-5.
40. Riboli E, Hunt KJ, Slimani N, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
41. Wareham NJ, Jakes RW, Rennie KL, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European prospective investigation into cancer and nutrition (EPIC) study. Public Health Nutr 2003; 6: 407-13.
42. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009; 41: 986-90.
43. Willett WC,. Nutritional Epidemiology, 2nd edn. New York: Oxford University Press, 1998.
44. Ahmed ML, Ong KK, Dunger DB,. Childhood obesity and the timing of puberty. Trends Endocrinol Metab 2009; 20: 237-42.
45. Keim SA, Branum AM, Klebanoff MA, et al. Maternal body mass index and daughters' age at menarche. Epidemiology 2009; 20: 677-81.
46. Mishra GD, Cooper R, Tom SE, et al. Early life circumstances and their impact on menarche and menopause. Womens Health (Lond Engl) 2009; 5: 175-90.
47. Terry MB, Ferris JS, Tehranifar P, et al. Birth weight, postnatal growth, and age at menarche. Am J Epidemiol 2009; 170: 72-9.
48. Bao Y, Giovannucci E, Fuchs CS, et al. Passive smoking and pancreatic cancer in women: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2292-6.
49. Guo Y, Xiong DH, Yang TL, et al. Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females. Hum Mol Genet 2006; 15: 2401-8.
50. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010; 42: 224-8.